The largest database of trusted experimental protocols

Ebioscience rbc lysis buffer

Manufactured by Thermo Fisher Scientific

The EBioscience RBC Lysis Buffer is a reagent used to selectively lyse red blood cells (RBCs) in a biological sample. It is designed to facilitate the isolation and analysis of other cell types, such as leukocytes, from the sample. The buffer's core function is to disrupt the RBC membranes, allowing for the effective removal of RBCs from the sample prior to further processing or analysis.

Automatically generated - may contain errors

6 protocols using ebioscience rbc lysis buffer

1

Isolation of Mouse Brain and Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anaesthetized mice were perfused with 1X HBSS (10U/ml heparin) and forebrains, spinal cord and spleens were collected in ice-cold 1X HBSS. Brains were dissociated using the Papain Dissociation System (Worthington Biochemical) by gentle sequential trituration, before and after incubation of 30 min at 37°C and 5% CO2. Single cell suspensions were filtered through a 40 µm cell strainer (Falcon) and resuspended in 30% Percoll® (Sigma-Aldrich) in AutoMACS running buffer at room temperature and centrifuged for 15 min at 500 xg at room temperature with no brake to allow for formation of a floating myelin layer. Following myelin removal, pelleted cells were resuspended in AutoMACS running buffer (Miltenyi Biotec), filtered again, and centrifuged at 300 xg for 10 min to obtain an immune cell-enriched pellet. Spleens were homogenized by mechanical dissociation followed by red blood cell removal using 1X eBioscience RBC lysis buffer (ThermoFisher) for 10 min at room temperature and filtered through a 40 µm cell strainer.
+ Open protocol
+ Expand
2

Neutrophil Oxidative Burst Assay in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oxidative burst of blood neutrophils was evaluated in rats after 5 weeks of dLAN. In this procedure, 50 µl of whole blood was diluted 20 times with PBS containing 20 µM of 2′,7′-dichlorodihydrofluorescein diacetate (H2-DCF-DA; MilliporeSigma, USA; D6883) and incubated for 30 min at 37°C in the dark. Thereafter, each sample was divided into two equal parts; one part was stimulated with phorbol-12-myristate-13-acetate (PMA; MilliporeSigma; P8139) at a final concentration of 1 µM and one part served as the unstimulated control (dimethyl sulfoxide was added at a final concentration of 0.1%). After incubation (for 30 min at 37°C in the dark), the cells were washed with PBS and red blood cells were lysed using eBioscience™ RBC Lysis Buffer (Thermo Fisher Scientific; 00-4333-57). After lysis of erythrocytes, the cells were washed, resuspended in 0.3 ml of PBS, and analyzed on a flow cytometer. Within the cell, H2-DCF-DA is converted to fluorescent 2′,7′-dichlorofluorescein (DCF), and this fluorescence is a measure of H2O2 production and is linearly related to the oxidative burst of the stimulated neutrophils (28 (link)). The functional activity of the neutrophils was expressed as a fold increase in the median DCF fluorescence of the PMA stimulated samples over the unstimulated samples.
+ Open protocol
+ Expand
3

SARS-CoV-2 S Peptide Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens from mice were collected and processed into single-cell suspensions in RPMI1640 media supplemented with 10% heat-inactivated fetal calf serum and penicillin/streptomycin (R10 media). Red blood cells were lysed using eBioscience RBC lysis buffer (Thermo Fisher Scientific) and resuspended in R10 media to stop the lysis. Splenocytes were counted and 100,000 cells per well were added to the plates of the Mouse IFN-γ ELISpotPLUS (HRP) kit (Mabtech). Cells were then stimulated for 18 hours at 37°C with SARS-CoV-2 S PepTivator peptides (Miltenyi Biotec) or media alone as a negative control. Spots were developed as per the manufacturer’s instructions. Spots were quantified by eye and plotted as SFU per million cells.
+ Open protocol
+ Expand
4

NSG Mouse Model for AML Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies were carried out under protocols approved by the Johns Hopkins Institutional Animal Care and Use Committee. NSG (NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ) mice 6–8 weeks old were obtained from an internal colony that originated from the Jackson Laboratory (Bar Harbor, Maine). Mice were injected with 1×106 MV-4-11 cells modified for stable firefly luciferase (ffLuc) expression31 (link) or 5×104 MOLM-13.ffLuc cells32 (link) via tail vein on D0. NK-cell treatment was administered on D7 (10×106 cells) or D4, 7, and 10 (3×106 cells each). Mice were given D-luciferin (3 mg) by intraperitoneal injection, and bioluminescence (BL) was measured using IVIS Spectrum (In Vivo Imaging System). Data were analyzed using Living Image Software V.4.7.3 (PerkinElmer, Waltham, Massachusetts, USA). When indicated, peripheral blood (PB) was drawn via facial vein; red blood cells were lysed with eBioscience RBC Lysis Buffer (Thermo Fisher); and the remaining cells were analyzed with flow cytometry. Bone marrow and spleen were harvested, and tissues were analyzed with flow cytometry. Analysis of PB for cytokines (hIL-15, hTumor Necrosis Factor (TNF)-α, mouse interleukin (mIL)-6, and mIL-1β) was performed with ELISA (R&D Systems). Mice were euthanized when they exhibited >20% weight loss, hind limb paralysis, or moribund state as per protocol guidelines.
+ Open protocol
+ Expand
5

Immunophenotyping Glioblastoma Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
All studies were conducted with approval from the Massachusetts General Hospital Cancer Center Institutional Review Board or the Duke Cancer Center Institutional Review Board. All studies were conducted in accordance with recognized ethical guidelines (U.S. Common Rule, 45 CFR 46, 21 CFR 50, 21 CFR 56, 21 CFR 312, 21 CFR 812, and 45 CFR 164.508–514). with 21 treatment-naïve GBM patients undergoing primary surgical resection of intracranial GBM were included in the prospective collection of whole blood and tumor tissue. 15 healthy age-matched controls were included in the prospective collection of whole blood. Informed consent was obtained from all subjects. Blood specimens were collected into EDTA-containing tubes. All blood and tumor specimens were stored at room temperature and processed within 12 hours. All samples were labeled directly with antibodies for use in flow cytometry, and red blood cells subsequently lysed using eBioscience RBC lysis buffer (eBioscience, San Diego, CA). Cells were washed, fixed and analyzed on an LSRII FORTESSA flow cytometer (BD Bioscience, San Jose, CA).
+ Open protocol
+ Expand
6

Immunophenotyping of Blood and Effusion Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly collected blood samples were treated with Fc block (Miltenyi Biotech) and then subjected to red blood cell lysis (Thermo Fisher Scientific, eBioscience RBC Lysis Buffer). After spinning and washing with 2% FBS in PBS, cells were subjected to surface staining. For freshly collected effusion samples, the cells were subjected to red blood cell lysis after spinning, passed through a 40-μm cell strainer (FALCON), and stained. To detect nivolumab binding, samples were incubated with anti–human IgG4-PE or isotype control (Abcam) after Fc blocking. Antibody clone numbers for immune analysis are listed in the Supplemental Methods. Fixation/permeabilization buffers (Thermo Fisher Scientific, eBioscience Foxp3/Transcription Factor Staining Buffer Set) were used for intracellular staining.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!